Troglitazone halts diabetic glomerulosclerosis by blockade of mesangial expansion

Kidney International

Volumn 58, Issue 6, 2000, Pages 2341-2350

  McCarthy, Kevin John ^a,b,c   Routh, Robert Earl ^a,b,c   Shaw, Walter ^a,b,c   Walsh, Kathleen ^a,b,c   Welbourne, Tomas Charles ^a,b,c   Johnson, John Hardwick ^a,b,c  

^a LOUISIANA STATE UNIV MEDICAL CENTER   (United States)

^b Genetic Models Inc   (United States)

^c PFIZER INC   (United States)

Author keywords

Glomerulosclerosis; Interstitial fibrosis; Proteoglycans; Thiazolidindiones; Type 2 diabetes mellitus; ZDF Gmi(TM) rat

Indexed keywords

GLUCOSE; TROGLITAZONE;

ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DIABETIC NEPHROPATHY; GLOMERULOSCLEROSIS; GLUCOSE BLOOD LEVEL; HYPERCHOLESTEROLEMIA; HYPERGLYCEMIA; HYPERTRIGLYCERIDEMIA; KIDNEY FIBROSIS; MALE; MESANGIUM CELL; NON INSULIN DEPENDENT DIABETES MELLITUS; NONHUMAN; PRIORITY JOURNAL; RAT;

EID: 0033661968     PISSN: 00852538     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1523-1755.2000.00418.x     Document Type: Article

References (57)

1. The stages of diabetic renal disease: With emphasis on the stage of incipient diabetic nephropathy
2. Genesis and evolution of diabetic nephropathy
3. 35S-glycopeptide metabolism by diabetic glomeruli and aorta
4. Decreased de novo synthesis of glomerular proteoglycans in diabetes: Biochemical and autoradiographic evidence
5. 4 proteoglycans in streptozocin-induced diabetic rats
6. 35S]-sulfate incorporation into glomerular basement membrane glycosaminoglycans is decreased in experimental diabetes
7. Reduced synthesis of basement membrane heparan sulfate proteoglycan in streptozotocin-induced diabetic mice
8. Effect of diabetes on the glycosaminoglycan component of the human glomerular basement membrane
9. Connective tissue in diabetes mellitus: Biochemical alterations of the intercellular matrix with special reference to proteoglycans, collagens, and basement membranes
10. 4 proteoglycan by heparin from glomeruli of streptozocin-induced diabetic rats
11. Reduced content and abnormal distribution of anionic sites (acid proteoglycans) in the diabetic glomerular basement membrane
12. Heparan sulfate proteoglycan in the glomerular basement membrane in type I diabetes mellitus
13. Heparan sulfate proteoglycans are lost in patients with diabetic nephropathy
14. Reduced number of anionic sites is associated with glomerular basement thickening in the diabetic BB-rat
15. Diabetic glomerulosclerosis: Immunogold ultrastructural studies on the glomerular distribution of type IV collagen and heparan sulfate proteoglycan
16. Immunohistochemical localization of collagen VI in diabetic glomeruli
17. Cell and matrix components of the glomerular mesangium in type I diabetes
18. Selective proteinuria in diabetic nephropathy is associated with a relative decrease in glomerular basement membrane heparan sulfate
19. Differential effects of diabetes and glomerulonephritis on glomerular basement membrane composition
20. Early structural changes in glomerular capillaries and their relationship to long-term diabetic nephropathy
21. Fast accumulation of basement membrane material and the rate of morphological changes in acute experimental diabetic glomerular hypertrophy
22. Structural changes in the diabetic kidney
23. Glomerular size and structure in diabetes mellitus. II. Late abnormalities
24. Structural-functional relationships in diabetic nephropathy
25. Mesangial expansion as a central mechanism for loss of kidney function in diabetic patients
26. Diabetic glomerulopathy in man and experimental animal models
27. Immunological characterization of a basement membrane-specific chondroitin sulfate proteoglycan
28. cDNA cloning of the basement membrane chondroitin sulfate proteoglycan core protein, bamacan: A five domain structure including coiled-coil motifs
29. Basement membrane specific chondroitin sulfate proteoglycan is abnormally associated with the glomerular capillary basement membrane in diabetic rats
30. Underexpression of β-cell high Km glucose transporters in noninsulin-dependent diabetes
31. Characterization of a new oral antidiabetic agent CS-045: Studies in KK and ob/ob and Zucker fatty rats
32. Troglitazone (CS-045) ameliorates albuminuria in streptozocin-induced diabetic rats
33. Basement membrane chondroitin sulfate proteoglycans: Localization in adult rat tissues
34. Basement membrane proteoglycans in glomerular morphogenesis: Chondroitin sulfate proteoglycan is temporally and spatially restricted during development
35. Development of glomerular lesions in experimental long-term diabetes in the rat
36. Glomerular size and structure in diabetes mellitus
37. Characterization of CS-045, a new antidiabetic agent. II. Effects on glycemic control and pancreatic islet structure at a late stage of the diabetic syndrome in C57BL/KsJ-db/db mice
38. Evidence that down-regulation of β-cell glucose transporters in non-insulin dependent diabetes may be the cause of diabetic hyperglycemia
39. Glomerular permeability. I. Ferritin transfer across the normal glomerular capillary wall
40. Diabetic glomerulosclerosis: Electron and light microscopic studies
41. Collagen IV a3, a4, and a5 chains in rodent basal laminae: Sequence, distribution, association with laminins, and developmental switches
42. Agrin is a major heparan sulfate proteoglycan in the glomerular basement membrane
43. Molecular heterogeneity of basal laminae: Isoforms of laminin and type IV collagen at the neuromuscular junction and elsewhere
44. 2+ currents and not endothelial nitric oxide production
45. Differential vasoaetive effects of the insulin sensitizers rosiglitazone (BRL 49653) and troglitazone on human small arteries in vitro
46. Peroxisome proliferator-activated receptor-gamma agonist, rosiglitazone, protects against nephropathy and pancreatic islet abnormalities in Zucker Fatty rats
47. High glucose causes and increase in extracellular matrix proteins in cultured mesangial cells
48. Glucose enhances type IV collagen production in cultured rat glomerular mesangial cells
49. Nonenzymatic glycation of mesangial matrix and prolonged exposure of mesangial matrix to elevated glucose reduces collagen synthesis and proteoglycan charge
50. Impact of dietary fatty acid supplementation on renal injury in obese Zucker rats
51. Treatment of hyperlipidemia reduces glomerular injury in obese Zucker rats
52. Early glomerular changes in rats with dietary-induced hypercholesterolemia
53. Reduction of insulin and triglycerides delays glomerulosclerosis in obese Zucker rats
54. Induction of glomerulosclerosis by dietary lipids